ReviewCurrent oncology (Toronto, Ont.)2022
Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2.
Lauren Clarfield et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewCurrent oncology (Toronto, Ont.)2022
Lauren Clarfield et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.